Description
COAGULATION ANALYZERS COST PER REPORTABLE RESULTS
Modification chain · 15 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-04-29+$53,000= $53,000
- Mod P000012019-10-01+$127,200= $180,200
- Mod P000022020-09-26+$0= $180,200
- Mod P000032020-10-01+$127,200= $307,400
- Mod P000042020-12-02+$0= $307,400
- Mod P000052021-10-01+$127,200= $434,600
- Mod P000062022-04-14-$17,314= $417,286
- Mod P000072022-10-01+$127,200= $544,486
- Mod P000082023-01-03-$17,703= $526,783
- Mod P000092023-08-10+$0= $526,783
- Mod P000102023-08-17+$0= $526,783
- Mod P000132023-08-17+$0= $526,783
- Mod P000112023-10-01+$63,602= $590,385
- Mod P000162024-10-21-$9,246= $581,139
- Mod P000172024-12-02-$8,255= $572,884
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-04-29 | +$53,000 | $53,000 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00001· EXERCISE AN OPTION | 2019-10-01 | +$127,200 | $180,200 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2020-09-26 | +$0 | $180,200 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00003· EXERCISE AN OPTION | 2020-10-01 | +$127,200 | $307,400 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2020-12-02 | +$0 | $307,400 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00005· EXERCISE AN OPTION | 2021-10-01 | +$127,200 | $434,600 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2022-04-14 | −$17,314 | $417,286 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00007· EXERCISE AN OPTION | 2022-10-01 | +$127,200 | $544,486 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00008· OTHER ADMINISTRATIVE ACTION | 2023-01-03 | −$17,703 | $526,783 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00009· OTHER ADMINISTRATIVE ACTION | 2023-08-10 | +$0 | $526,783 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00010· OTHER ADMINISTRATIVE ACTION | 2023-08-17 | +$0 | $526,783 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00013· OTHER ADMINISTRATIVE ACTION | 2023-08-17 | +$0 | $526,783 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00011· EXERCISE AN OPTION | 2023-10-01 | +$63,602 | $590,385 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00016· CLOSE OUT | 2024-10-21 | −$9,246 | $581,139 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
| Mod P00017· FUNDING ONLY ACTION | 2024-12-02 | −$8,255 | $572,884 | COAGULATION ANALYZERS COST PER REPORTABLE RESULTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JA87HT8KP2M2)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0379 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $671,956 | FY2026 |
| 36C25626P0989 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $24,200 | FY2026 |
| 36C24126N0746 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,961 | FY2026 |
| 36C24126N0753 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $89,895 | FY2026 |
| 36C24126N0747 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $127,637 | FY2026 |
| 36C24126N0748 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $13,031 | FY2026 |
Other recipients under 6640 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826A0029 | ABBOTT LABORATORIES INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $0 | FY2026 |
| 36C24826N0821 | ABBOTT LABORATORIES INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $289,849 | FY2026 |
| 36C24826P1068 | CEPHEID | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $63,150 | FY2026 |
| 36C24826P1104 | HOLOGIC SALES AND SERVICE, LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $263,800 | FY2026 |
| 36C24826P1126 | TRILLAMED LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $25,838 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24819F0206_3600_V797D30108_3600 · retrieved 2026-09-26.